Literature DB >> 33151297

PK-DB: pharmacokinetics database for individualized and stratified computational modeling.

Jan Grzegorzewski1, Janosch Brandhorst1, Kathleen Green2, Dimitra Eleftheriadou1, Yannick Duport3, Florian Barthorscht1, Adrian Köller1, Danny Yu Jia Ke4, Sara De Angelis5, Matthias König1.   

Abstract

A multitude of pharmacokinetics studies have been published. However, due to the lack of an open database, pharmacokinetics data, as well as the corresponding meta-information, have been difficult to access. We present PK-DB (https://pk-db.com), an open database for pharmacokinetics information from clinical trials. PK-DB provides curated information on (i) characteristics of studied patient cohorts and subjects (e.g. age, bodyweight, smoking status, genetic variants); (ii) applied interventions (e.g. dosing, substance, route of application); (iii) pharmacokinetic parameters (e.g. clearance, half-life, area under the curve) and (iv) measured pharmacokinetic time-courses. Key features are the representation of experimental errors, the normalization of measurement units, annotation of information to biological ontologies, calculation of pharmacokinetic parameters from concentration-time profiles, a workflow for collaborative data curation, strong validation rules on the data, computational access via a REST API as well as human access via a web interface. PK-DB enables meta-analysis based on data from multiple studies and data integration with computational models. A special focus lies on meta-data relevant for individualized and stratified computational modeling with methods like physiologically based pharmacokinetic (PBPK), pharmacokinetic/pharmacodynamic (PK/PD), or population pharmacokinetic (pop PK) modeling.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2021        PMID: 33151297      PMCID: PMC7779054          DOI: 10.1093/nar/gkaa990

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.

Authors:  Tiago L Moda; Leonardo G Torres; Alexandre E Carrara; Adriano D Andricopulo
Journal:  Bioinformatics       Date:  2008-08-06       Impact factor: 6.937

2.  Evidence for morphine-independent central nervous opioid effects after administration of codeine: contribution of other codeine metabolites.

Authors:  Jörn Lötsch; Carsten Skarke; Helmut Schmidt; Maren Rohrbacher; Ute Hofmann; Matthias Schwab; Gerd Geisslinger
Journal:  Clin Pharmacol Ther       Date:  2006-01       Impact factor: 6.875

3.  Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement.

Authors:  Salmaan Kanji; Meghan Hayes; Adam Ling; Larissa Shamseer; Clarence Chant; David J Edwards; Scott Edwards; Mary H H Ensom; David R Foster; Brian Hardy; Tyree H Kiser; Charles la Porte; Jason A Roberts; Rob Shulman; Scott Walker; Sheryl Zelenitsky; David Moher
Journal:  Clin Pharmacokinet       Date:  2015-07       Impact factor: 6.447

Review 4.  Reproducible pharmacokinetics.

Authors:  John P A Ioannidis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-04-19       Impact factor: 2.745

5.  Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics.

Authors:  C A Beach; D C Mays; R C Guiler; C H Jacober; N Gerber
Journal:  Clin Pharmacol Ther       Date:  1986-03       Impact factor: 6.875

6.  Population pharmacokinetics of caffeine in healthy male adults using mixed-effects models.

Authors:  K-Y Seng; C-Y Fun; Y-L Law; W-M Lim; W Fan; C-L Lim
Journal:  J Clin Pharm Ther       Date:  2009-02       Impact factor: 2.512

7.  Basic concepts in population modeling, simulation, and model-based drug development.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-09-26

8.  Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.

Authors:  D R Mould; R N Upton
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-04-17

9.  Database of pharmacokinetic time-series data and parameters for 144 environmental chemicals.

Authors:  Risa R Sayre; John F Wambaugh; Christopher M Grulke
Journal:  Sci Data       Date:  2020-04-20       Impact factor: 6.444

10.  The FAIR Guiding Principles for scientific data management and stewardship.

Authors:  Mark D Wilkinson; Michel Dumontier; I Jsbrand Jan Aalbersberg; Gabrielle Appleton; Myles Axton; Arie Baak; Niklas Blomberg; Jan-Willem Boiten; Luiz Bonino da Silva Santos; Philip E Bourne; Jildau Bouwman; Anthony J Brookes; Tim Clark; Mercè Crosas; Ingrid Dillo; Olivier Dumon; Scott Edmunds; Chris T Evelo; Richard Finkers; Alejandra Gonzalez-Beltran; Alasdair J G Gray; Paul Groth; Carole Goble; Jeffrey S Grethe; Jaap Heringa; Peter A C 't Hoen; Rob Hooft; Tobias Kuhn; Ruben Kok; Joost Kok; Scott J Lusher; Maryann E Martone; Albert Mons; Abel L Packer; Bengt Persson; Philippe Rocca-Serra; Marco Roos; Rene van Schaik; Susanna-Assunta Sansone; Erik Schultes; Thierry Sengstag; Ted Slater; George Strawn; Morris A Swertz; Mark Thompson; Johan van der Lei; Erik van Mulligen; Jan Velterop; Andra Waagmeester; Peter Wittenburg; Katherine Wolstencroft; Jun Zhao; Barend Mons
Journal:  Sci Data       Date:  2016-03-15       Impact factor: 6.444

View more
  5 in total

Review 1.  Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.

Authors:  Jan Grzegorzewski; Florian Bartsch; Adrian Köller; Matthias König
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

2.  DDPD 1.0: a manually curated and standardized database of digital properties of approved drugs for drug-likeness evaluation and drug development.

Authors:  Qiang Li; Shiyong Ma; Xuelu Zhang; Zhaoyu Zhai; Lu Zhou; Haodong Tao; Yachen Wang; Jianbo Pan
Journal:  Database (Oxford)       Date:  2022-02-09       Impact factor: 4.462

3.  Anti-Inflammatory and Anti-Rheumatic Potential of Selective Plant Compounds by Targeting TLR-4/AP-1 Signaling: A Comprehensive Molecular Docking and Simulation Approaches.

Authors:  Ashrafullah Khan; Shafi Ullah Khan; Adnan Khan; Bushra Shal; Sabih Ur Rehman; Shaheed Ur Rehman; Thet Thet Htar; Salman Khan; Sirajudheen Anwar; Ahmed Alafnan; Kannan Rr Rengasamy
Journal:  Molecules       Date:  2022-07-05       Impact factor: 4.927

4.  The first 10 years of the international coordination network for standards in systems and synthetic biology (COMBINE).

Authors:  Dagmar Waltemath; Martin Golebiewski; Michael L Blinov; Padraig Gleeson; Henning Hermjakob; Michael Hucka; Esther Thea Inau; Sarah M Keating; Matthias König; Olga Krebs; Rahuman S Malik-Sheriff; David Nickerson; Ernst Oberortner; Herbert M Sauro; Falk Schreiber; Lucian Smith; Melanie I Stefan; Ulrike Wittig; Chris J Myers
Journal:  J Integr Bioinform       Date:  2020-06-29

5.  An automated approach to identify scientific publications reporting pharmacokinetic parameters.

Authors:  Ferran Gonzalez Hernandez; Simon J Carter; Juha Iso-Sipilä; Paul Goldsmith; Ahmed A Almousa; Silke Gastine; Watjana Lilaonitkul; Frank Kloprogge; Joseph F Standing
Journal:  Wellcome Open Res       Date:  2021-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.